WilmerHale Shortlisted for Life Sciences IP Litigation Firm of the Year at the 2026 LSPN Awards

 WilmerHale Shortlisted for Life Sciences IP Litigation Firm of the Year at the 2026 LSPN Awards

Recognition

Related Solutions

Clients trust us to protect their most important intellectual property matters.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

WilmerHale has been shortlisted for Life Sciences IP Litigation Firm of the Year in the LSPN Awards USA 2026, which recognize excellence, innovation and leadership across the life sciences intellectual property community.

The LSPN Awards highlight firms and practitioners shaping the future of pharmaceutical and biotechnology patent protection in the United States. WilmerHale’s inclusion highlights the depth of its life sciences IP litigation practice and its work on some of the most challenging disputes in the field.

Finalists for the 2026 awards were selected following a competitive process recognizing outstanding contributions across a wide range of life sciences IP categories. 

Winners will be announced at the LSPN Awards ceremony on April 30, 2026, in Boston.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel